Infographic
How Pharma Companies Can Gain an Edge with M&A
As dealmaking becomes more competitive and expensive, the margin for error is shrinking. Companies need to double down on M&A fundamentals.
Auteurs
Kai Grass
Associé, Dusseldorf
Sarwar Islam
Associé, London
Floriane Haas-Falanga
Associate Partner, Munich
Andy Pasternak
Advisory Partner, Chicago
First published in juillet 2024